Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

DL-Pyroglutamic acid

Copy Product Info
😃Good
Catalog No. T9371Cas No. 149-87-1

DL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen. 

DL-Pyroglutamic acid

DL-Pyroglutamic acid

Copy Product Info
😃Good
Purity: 99.88%
Catalog No. T9371Cas No. 149-87-1
DL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen. 
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 g$29-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.88%
Appearance:solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

DL-Pyroglutamic acid AI Summary
DL-Pyroglutamic acid demonstrates inhibition of pyroglutamylaminopeptidase at different doses, relative to Pyrrolidin-2-one-CO-Gly-Ile and 2-Oxo-hexahydro-pyrimidine-4-carboxylic acid, affecting hydrolysis rates. Additionally, it shows bioactivities as an inhibitor in various assays: it inhibits AmpC Beta-Lactamase with a potency of 39810.7 nM, Nrf2 signaling with a potency of 25929.0 nM, Chronic Active B-Cell Receptor Signaling with a potency of 4466.8 nM, and the malarial parasite plastid with potencies of 6573.3 nM in a 96-hour assay and 58.6 nM in a 48-hour assay..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
DL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen. 
Chemical Properties
Molecular Weight129.11
FormulaC5H7NO3
Cas No.149-87-1
SmilesC(O)(=O)C1NC(=O)CC1
Relative Density.1.38 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (387.27 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (15.49 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM7.7453 mL38.7267 mL77.4533 mL387.2667 mL
5 mM1.5491 mL7.7453 mL15.4907 mL77.4533 mL
10 mM0.7745 mL3.8727 mL7.7453 mL38.7267 mL
20 mM0.3873 mL1.9363 mL3.8727 mL19.3633 mL
50 mM0.1549 mL0.7745 mL1.5491 mL7.7453 mL
100 mM0.0775 mL0.3873 mL0.7745 mL3.8727 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DL-Pyroglutamic acid | purchase DL-Pyroglutamic acid | DL-Pyroglutamic acid cost | order DL-Pyroglutamic acid | DL-Pyroglutamic acid chemical structure | DL-Pyroglutamic acid formula | DL-Pyroglutamic acid molecular weight